205 related articles for article (PubMed ID: 17033262)
1. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
Løvås K; Thorsen TE; Husebye ES
J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
[TBL] [Abstract][Full Text] [Related]
2. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
Smans L; Lentjes E; Hermus A; Zelissen P
Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
[TBL] [Abstract][Full Text] [Related]
3. Variable sensitivity to the glucocorticoid activity of cortisol in patients with primary adrenal insufficiency: assessment with ACTH profiles.
Ekman B; Blomgren J; Andersson PO; Carlsson M; Arnqvist HJ
Horm Metab Res; 2010 Dec; 42(13):961-6. PubMed ID: 20925018
[TBL] [Abstract][Full Text] [Related]
4. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
Ross IL; Lacerda M; Pillay TS; Blom DJ; Johannsson G; Dave JA; Levitt NS; Haarburger D; van der Walt JS
Horm Metab Res; 2016 Dec; 48(12):814-821. PubMed ID: 27813051
[TBL] [Abstract][Full Text] [Related]
5. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N
Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810
[TBL] [Abstract][Full Text] [Related]
6. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
Ross IL; Levitt NS; Van der Walt JS; Schatz DA; Johannsson G; Haarburger DH; Pillay TS
Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258
[TBL] [Abstract][Full Text] [Related]
7. Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease.
Methlie P; Husebye EE; Hustad S; Lien EA; Løvås K
Eur J Endocrinol; 2011 Nov; 165(5):761-9. PubMed ID: 21896619
[TBL] [Abstract][Full Text] [Related]
8. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
[TBL] [Abstract][Full Text] [Related]
9. Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement.
Feek CM; Ratcliffe JG; Seth J; Gray CE; Toft AD; Irvine WJ
Clin Endocrinol (Oxf); 1981 May; 14(5):451-8. PubMed ID: 6273020
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey SR; Guo CY; Robinson AM; Price A; Giles MA; Eastell R; Weetman AP
Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031
[TBL] [Abstract][Full Text] [Related]
11. ACTH suppression after oral administration of cortisone in Addisonian and adrenalectomized patients.
Aanderud S; Myking OL; Bassøe HH
Acta Endocrinol (Copenh); 1982 Aug; 100(4):588-94. PubMed ID: 6289586
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
Oksnes M; Björnsdottir S; Isaksson M; Methlie P; Carlsen S; Nilsen RM; Broman JE; Triebner K; Kämpe O; Hulting AL; Bensing S; Husebye ES; Løvås K
J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
[TBL] [Abstract][Full Text] [Related]
13. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
Fichna M; Gryczyńska M; Sowińska A; Sowiński J
Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
[TBL] [Abstract][Full Text] [Related]
14. Salivary cortisone is a potential biomarker for serum free cortisol.
Perogamvros I; Keevil BG; Ray DW; Trainer PJ
J Clin Endocrinol Metab; 2010 Nov; 95(11):4951-8. PubMed ID: 20685855
[TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous hydrocortisone infusion in Addison's disease.
Løvås K; Husebye ES
Eur J Endocrinol; 2007 Jul; 157(1):109-12. PubMed ID: 17609409
[TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
[TBL] [Abstract][Full Text] [Related]
17. Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency.
Ceccato F; Albiger N; Reimondo G; Frigo AC; Ferasin S; Occhi G; Mantero F; Terzolo M; Scaroni C
Eur J Endocrinol; 2012 Dec; 167(6):769-76. PubMed ID: 23034783
[TBL] [Abstract][Full Text] [Related]
18. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.
Giordano R; Guaraldi F; Marinazzo E; Fumarola F; Rampino A; Berardelli R; Karamouzis I; Lucchiari M; Manetta T; Mengozzi G; Arvat E; Ghigo E
Endocrine; 2016 Feb; 51(2):360-8. PubMed ID: 26184416
[TBL] [Abstract][Full Text] [Related]
19. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
Camozzi V; Betterle C; Frigo AC; Zaccariotto V; Zaninotto M; De Caneva E; Lucato P; Gomiero W; Garelli S; Sabbadin C; Salvà M; Costa MD; Boscaro M; Luisetto G
Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
[TBL] [Abstract][Full Text] [Related]
20. Serum cortisol appearance-disappearance in adrenal insufficiency after oral cortisone acetate.
Barbato AL; Landau RL
Acta Endocrinol (Copenh); 1977 Mar; 84(3):600-4. PubMed ID: 576533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
